Thomas Andrew Davis Genocea Biosciences, Inc. (GNCA) insider trading activity

GNCA Quotes by TradingView

Thomas Andrew Davis is CHIEF MEDICAL OFFICER of GENOCEA BIOSCIENCES, INC.. Currently has a direct ownership of 68,330 shares of GNCA, which is worth approximately $0. The most recent transaction as insider was on Apr 04, 2022, when has been sold 1,091 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $1,364. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.3K
0% 3M change
0% 12M change
Total Value Held $0

Thomas Andrew Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 04 2022
SELL
Open market or private sale
$1,364 $1.25 p/Share
1,091 Reduced 1.57%
68,330 Common Stock
Mar 16 2022
SELL
Open market or private sale
$2,989 $1.1 p/Share
2,717 Reduced 3.77%
69,421 Common Stock
Mar 15 2022
BUY
Grant, award, or other acquisition
-
31,250 Added 30.23%
72,138 Common Stock
Mar 15 2021
BUY
Grant, award, or other acquisition
-
31,250 Added 50.0%
31,250 Common Stock
TAD

Thomas Andrew Davis

CHIEF MEDICAL OFFICER
Cambridge, MA

Track Institutional and Insider Activities on GNCA

Follow GENOCEA BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GNCA shares.

Notify only if

Insider Trading

Get notified when an Genocea Biosciences, Inc. insider buys or sells GNCA shares.

Notify only if

News

Receive news related to GENOCEA BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GNCA